• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过与乙醇胺成盐提高吡罗昔康的生物利用度。

Enhanced bioavailability of piroxicam via salt formation with ethanolamines.

作者信息

Gwak Hye-Sun, Choi Jun-Shik, Choi Hoo-Kyun

机构信息

College of Pharmacy, Ewha Women's University, Seoul 120-750, Republic of Korea.

出版信息

Int J Pharm. 2005 Jun 13;297(1-2):156-61. doi: 10.1016/j.ijpharm.2005.03.016. Epub 2005 Apr 25.

DOI:10.1016/j.ijpharm.2005.03.016
PMID:15907602
Abstract

Piroxicam can be ionized as a zwitterion that has two pKa values (pKa1=1.86 and pKa2=5.46). Consequently, piroxicam has a low solubility in both polar and nonpolar media, and a low lipophilicity, which results in a low permeability. Three piroxicam-ethanolamine salts were prepared, which had a higher area under the curve (AUC) than piroxicam. There were minimal differences in the AUC among the salt forms. It was reported that the piroxicam triethanolamine salt had a lower permeability across the skin than piroxicam but it had a higher oral bioavailability. Piroxicam monoethanolamine showed the highest Cmax followed by piroxicam diethanolamine and piroxicam triethanolamine. The dissolution rates of piroxicam and its salts were similar at pH 1.2. Piroxicam monoethanolamine showed the highest dissolution rate at pH 6.8, which was followed by the piroxicam diethanolamine and piroxicam triethanolamine salts. The order of dissolution rate at pH 6.8 matched the order of Cmax or the AUC after oral administration.

摘要

吡罗昔康可离子化为两性离子,有两个pKa值(pKa1 = 1.86和pKa2 = 5.46)。因此,吡罗昔康在极性和非极性介质中的溶解度都很低,亲脂性也低,这导致其渗透性较低。制备了三种吡罗昔康 - 乙醇胺盐,它们的曲线下面积(AUC)比吡罗昔康更高。盐形式之间的AUC差异极小。据报道,吡罗昔康三乙醇胺盐经皮渗透性比吡罗昔康低,但口服生物利用度更高。吡罗昔康单乙醇胺的Cmax最高,其次是吡罗昔康二乙醇胺和吡罗昔康三乙醇胺。吡罗昔康及其盐在pH 1.2时的溶解速率相似。吡罗昔康单乙醇胺在pH 6.8时的溶解速率最高,其次是吡罗昔康二乙醇胺盐和吡罗昔康三乙醇胺盐。pH 6.8时的溶解速率顺序与口服给药后的Cmax或AUC顺序一致。

相似文献

1
Enhanced bioavailability of piroxicam via salt formation with ethanolamines.通过与乙醇胺成盐提高吡罗昔康的生物利用度。
Int J Pharm. 2005 Jun 13;297(1-2):156-61. doi: 10.1016/j.ijpharm.2005.03.016. Epub 2005 Apr 25.
2
Improved absorption of meloxicam via salt formation with ethanolamines.通过与乙醇胺形成盐来提高美洛昔康的吸收。
Eur J Pharm Biopharm. 2007 Jan;65(1):99-103. doi: 10.1016/j.ejpb.2006.07.003. Epub 2006 Jul 15.
3
Pharmacokinetics of formulated tenoxicam transdermal delivery systems.成方替诺昔康透皮给药系统的药代动力学
J Pharm Pharmacol. 2008 Jan;60(1):135-8. doi: 10.1211/jpp.60.1.0017.
4
Enhanced percutaneous absoption of piroxicam via salt formation with ethanolamines.通过与乙醇胺形成盐来增强吡罗昔康的经皮吸收。
Pharm Res. 2002 Sep;19(9):1375-80. doi: 10.1023/a:1020367212307.
5
Solid-state dependent dissolution and oral bioavailability of piroxicam in rats.固体状态依赖性溶解和吡罗昔康在大鼠体内的口服生物利用度。
Eur J Pharm Sci. 2013 Jan 23;48(1-2):47-54. doi: 10.1016/j.ejps.2012.10.005. Epub 2012 Oct 22.
6
Biowaiver monographs for immediate release solid oral dosage forms: piroxicam.速释固体口服剂型的生物豁免说明书:吡罗昔康。
J Pharm Sci. 2014 Feb;103(2):367-77. doi: 10.1002/jps.23799. Epub 2013 Dec 2.
7
Enhanced oral bioavailability of piroxicam in rats by hyaluronate microspheres.透明质酸微球提高大鼠体内吡罗昔康的口服生物利用度。
Drug Dev Ind Pharm. 2007 Apr;33(4):485-91. doi: 10.1080/03639040600865223.
8
Rheological characterization and in vivo evaluation of thermosensitive poloxamer-based hydrogel for intramuscular injection of piroxicam.用于吡罗昔康肌内注射的温敏泊洛沙姆水凝胶的流变学特性及体内评价。
Int J Pharm. 2010 Aug 16;395(1-2):317-23. doi: 10.1016/j.ijpharm.2010.05.042. Epub 2010 Jun 4.
9
Enhancement of dissolution and bioavailability of piroxicam in solid dispersion systems.吡罗昔康在固体分散体系统中的溶出度和生物利用度的提高。
Drug Dev Ind Pharm. 2000 Sep;26(9):989-94. doi: 10.1081/ddc-100101327.
10
Enhanced bioavailability of piroxicam using Gelucire 44/14 and labrasol: in vitro and in vivo evaluation.使用Gelucire 44/14和Labrasol提高吡罗昔康的生物利用度:体内外评价
Eur J Pharm Biopharm. 2003 Nov;56(3):453-9. doi: 10.1016/s0939-6411(03)00142-5.

引用本文的文献

1
Pharmaceutical Salts of Piroxicam and Meloxicam with Organic Counterions.吡罗昔康和美洛昔康与有机抗衡离子形成的药用盐。
Cryst Growth Des. 2022 Oct 21;22(11):6504-6520. doi: 10.1021/acs.cgd.2c00722. eCollection 2022 Nov 2.
2
Ketoprofen-FA Co-crystal: In Vitro and In Vivo Investigation for the Solubility Enhancement of Drug by Design of Expert.酮洛芬 FA 共晶:专家设计用于提高药物溶解度的体外和体内研究。
AAPS PharmSciTech. 2022 Mar 29;23(4):101. doi: 10.1208/s12249-022-02253-5.
3
Preparation and physicochemical properties of vinblastine microparticles by supercritical antisolvent process.
超临界抗溶剂法制备长春碱微粒及其理化性质
Int J Mol Sci. 2012 Oct 3;13(10):12598-607. doi: 10.3390/ijms131012598.
4
Fabrication, modeling and characterization of multi-crosslinked methacrylate copolymeric nanoparticles for oral drug delivery.用于口服给药的多交联甲基丙烯酸酯共聚物纳米颗粒的制备、建模与表征
Int J Mol Sci. 2011;12(9):6194-225. doi: 10.3390/ijms12096194. Epub 2011 Sep 23.
5
Modulating pharmacokinetics, tumor uptake and biodistribution by engineered nanoparticles.通过工程化纳米颗粒调节药代动力学、肿瘤摄取和生物分布。
PLoS One. 2011;6(9):e24374. doi: 10.1371/journal.pone.0024374. Epub 2011 Sep 13.